Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

  • This share is currently suspended. It was suspended at a price of 0.75
  • There is currently no data for BELL

Proposed Board Appointment

26 May 2023 07:00

RNS Number : 7364A
Belluscura PLC
26 May 2023
 

 

Belluscura plc

("Belluscura", the "Company" or the "Group")

Proposed Board Appointment

 

Further to the announcement at 11:00 a.m on 25 May 2023 ("Fundraising Announcement") the following information is notified in relation to Bob Fary, currently the Group's VP of Global Sales. It is proposed that Mr Fary will join the board as an Executive Director subject to satisfactory completion of the requisite due diligence and nominated adviser checks.

Full name: Robert (Bob) Sylvester Fary

Age: 65 years old

Mr Fary currently holds the following directorships/partnerships:

None

Directorships and partnerships held within the last five years:

American Associate for Homecare

Mr Fary currently holds 400,000 options in the Company. As notified in the Fundraising Announcement he has subscribed for 32,000 new ordinary shares in the Subscription.

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 **ENDS**

 For further information please contact:

 

Belluscura plc

www.belluscura.com

Adam Reynolds, Non-Executive Chairman

via MHP

Robert Rauker, Chief Executive Officer

Anthony Dyer, Chief Financial Officer

 

SPARK Advisory Partners Limited (Nominated Adviser)

Tel: +44 (0)20 3368 3550

Neil Baldwin

 

Dowgate Capital Limited (Broker)

Tel: +44 (0)20 3903 7715

James Serjeant / Russell Cook / Nicholas Chambers

MHP (Financial PR & Investor Relations)

Tel: +44 (0)20 3128 8100

Katie Hunt / Pete Lambie / Matthew Taylor

email: belluscura@mhpgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAAMMTMTBTTFJ
Date   Source Headline
2nd Dec 20257:00 amRNSCancellation - Belluscura plc
5th Nov 20259:47 amRNSIntention to appoint Administrator Update
31st Oct 202512:15 pmRNSIntention to appoint Administrator
30th Oct 202511:30 amRNSReplacement Statement re US Subsidiary Update
30th Oct 202510:38 amRNSStatement re US Subsidiary Chapter 7 Update
28th Oct 20255:32 pmRNSUpdate re Proposed Fundraise
22nd Sep 20257:00 amRNSDirectorate Change
12th Sep 20254:57 pmRNSBoard Appointment
26th Aug 20256:00 pmRNSSuspended Companies Notice - Deletion
11th Aug 20257:00 amRNSUpdate re Strategic Review and Proposed Fundraise
1st Jul 20257:30 amRNSSuspension - Belluscura PLC
30th Jun 20257:00 amRNSStrategic Review Update and Proposed Fundraising
19th Jun 202511:07 amRNSHolding(s) in Company - Replacement
18th Jun 20255:01 pmRNSHolding(s) in Company
13th May 202512:54 pmRNSResponse to Share Price Movement
9th May 20257:00 amRNSTrading update & commencement of strategic review
16th Apr 20257:00 amRNSTrading Update and Directorate Change
8th Apr 20252:45 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSStatement re proposed imposition of Tariffs
27th Mar 20253:15 pmRNSHolding(s) in Company
10th Mar 20255:49 pmRNSHolding(s) in Company
6th Mar 20254:21 pmRNSHolding(s) in Company
6th Mar 20251:08 pmRNSHolding(s) in Company
5th Mar 20252:21 pmRNSHolding(s) in Company
4th Mar 20253:50 pmRNSHolding(s) in Company
28th Feb 20253:44 pmRNSReplacement: Result of General Meeting
28th Feb 20251:32 pmRNSResult of General Meeting
13th Feb 20257:30 amRNSHolding(s) in Company
12th Feb 20257:00 amRNSPosting of Circular and Notice of General Meeting
11th Feb 20257:00 amRNSResult of oversubscribed WRAP Retail Offer
7th Feb 20257:05 amRNSLaunch of WRAP Retail Offer
7th Feb 20257:00 amRNSResult of Share Placing
6th Feb 20255:22 pmRNSProposed Share Placing
5th Feb 20257:30 amRNSRule 19.6(c) confirmation of post-offer intentions
20th Dec 20243:20 pmRNSAppointment of Allenby Capital as Joint Broker
11th Dec 20243:21 pmRNSHolding(s) in Company
22nd Nov 20247:00 amRNSNew $4million Credit Facility
12th Nov 20244:34 pmRNSHolding(s) in Company
28th Oct 20247:00 amRNSTrading Update
26th Sep 20247:00 amRNSHalf-year Report
13th Sep 20241:37 pmRNSHolding(s) in Company
12th Sep 20243:05 pmRNSHolding(s) in Company
27th Aug 20242:17 pmRNSResult of General Meeting
27th Aug 20247:00 amRNSAGM Trading Statement
2nd Aug 20247:00 amRNSNotice of AGM
31st Jul 20241:11 pmRNSTotal Voting Rights
19th Jul 202410:36 amRNSDirector/PDMR Shareholding
11th Jul 202411:30 amRNSDirectorate Change
8th Jul 202412:45 pmRNSResult of General Meeting
4th Jul 20241:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.